Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$119,320,390
+$15,099,835 QoQ
Shares Held
474,171
-1.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#230
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $679,497,428 across 14 Drug Manufacturers - General names. ABBV ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
247,625 | $297,008,878 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
474,171 | $119,320,390 | |
| 3 | JNJ |
Johnson & Johnson
|
393,933 | $100,047,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
370,246 | $47,576,611 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
203,044 | $25,652,578 | |
| 6 | PFE |
Pfizer Inc
|
1,059,033 | $25,501,514 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
384,190 | $22,137,027 | |
| 8 | NVS |
Novartis AG
|
89,153 | $13,972,058 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,320,390 | 474,171 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $104,220,555 | 479,197 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $109,462,475 | 479,069 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $112,150,103 | 484,366 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $89,177,230 | 480,429 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $101,484,364 | 484,366 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $86,688,634 | 487,837 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $104,427,818 | 528,802 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $73,298,557 | 427,347 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||